Medical genomics is the application and integration of genomic and other data—including functional genomics, genome structure, genome-scale population genetics, epigenomics, proteomics, systems analysis, and pharmacogenomics—to better understand the genetic bases of drug response and disease.
This new approach to health care uses the knowledge of an individual's genomic make-up to identify those that are at a higher risk of developing certain conditions and intervene at an earlier stage to prevent these diseases.
The webinar on 16 July will explore how genomic medicine can contribute to improved health outcomes, in particular concerning the forthcoming European Union Horizon Europe framework programme for research and development, which is scheduled to begin on 1 January 2021.
Speakers will include:
· Anne Jones, COO, Genuity Science
· Kurt Zatloukal, Professor of Pathology, Medical University Graz, Styria, Austria
· Rainer Fischer, President's Fellow in the Life Sciences, Purdue University, USA
· Robert Eiss, Senior Advisor to Fogarty International Director, Dr. Roger I. Glass, National Institutes of Health, USA
· Desmond Barry, IMI2, Brussels
· Daria Julkowska, INSERM, France
· Karen Holmes, VP, Head of Legal and Data Privacy, Genuity Science, Ireland
· Dyann Heward-Mills, CEO, HewardMills Ltd, UK
· Rita Lawlor, Biobank Director CIPP/E, CIPM, IAPP Fellow of Information Privacy, Italy
· Peter Goodhand, The Global Alliance for Genomics and Health (GA4GH), Canada
· Serena Scollen, Head of Human Genomics and Translational Data at ELIXIR, Cambridge, United Kingdom
· David Kavanagh, Director of Clinical Partnerships, Genuity Science, Ireland
· Alan Christoffels, South African Medical Research Council, South Africa
· Alfonso Valencia, ICREA Research Professor, Dir. Life Sciences Dpt , Barcelona Supercomputing Center